Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Ischemia-induced local release of myocardial noradrenaline

Journal Article · · J. Cardiovasc. Pharmacol.; (United States)
The isolated perfused rat heart, prelabelled with /sup 3/H-noradrenaline (NA), was used to examine the ischemia-induced release of myocardial NA, and to investigate to what extent reperfusion of an ischemic myocardium per se causes a release of NA. In a model of global myocardial ischemia with 90% flow reduction and the use of lactate as perfusion substrate, release of /sup 3/H-NA into the perfusate was already observed during the first 10-20 min of ischemia. The quantities of /sup 3/H-NA released increased further with increasing duration of ischemia. In another model with regional ischemia produced by left coronary artery ligation, a similar, though less marked, release of /sup 3/H-NA into the perfusate was observed during ischemia. Reperfusion after 60 min of ischemia was associated with a marked outflow of /sup 3/H-NA and /sup 3/H-NA metabolites, which was not reduced if reperfusion was performed with a Ca2+-free buffer. Furthermore, in the globally ischemic heart model, the relative amounts of /sup 3/H-NA and the various /sup 3/H-NA metabolites in the effluent remained constant during the last minute of ischemia and the first minute of reperfusion. The authors concluded that ischemia is associated with early local release of myocardial NA. NA can partly be trapped in the ischemic tissue and washed out during reperfusion.
Research Organization:
Haessle Cardiovascular Research Labs., Moelndal, Sweden
OSTI ID:
5018720
Journal Information:
J. Cardiovasc. Pharmacol.; (United States), Journal Name: J. Cardiovasc. Pharmacol.; (United States); ISSN JCPCD
Country of Publication:
United States
Language:
English